News
3mon
Clinical Trials Arena on MSNArrowhead doses first patient in Phase I/IIa RNA obesity therapy trialThe investigational therapy works to impede the expression of genes that cause the body to store fat as a potential treatment for patients living with obesity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results